Preprint · CC-BY
via OpenAlex
What Is Aging, and How Can We Defeat It?
Preprints.org · 2025
Genomic instability
Mitochondrial dysfunction
Cellular senescence
Stem-cell exhaustion
Chronic inflammation
Caloric restriction
Metformin
Partial reprogramming (OSK)
Senolytics
Human
Review
Abstract
Aging is not an immutable fate but a malleable biological process driven by interconnected molecular, cellular, and systemic failures. While modern medicine excels at managing acute conditions, it largely fails to address the root cause of most chronic diseases – aging itself. In this review, I synthesize current evidence that aging arises from the interplay of stochastic damage and evolutionarily shaped regulatory programs (exemplified by conserved parameters such as AROCM) and manifests through the telomere(definition) attrition, cellular senescence(definition))." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">hallmarks of aging(definition), including genomic instability, proteostatic collapse, mitochondrial dysfunction(definition), cellular senescence, and inflammaging(definition), ultimately driving chronic disease across organ systems. I argue that defeating aging requires a strategic shift from symptom palliation to restoration of youthful function, achieved through three synergistic pillars: (1) elimination of damage (e.g., senolytics(definition), monoclonal antibodies against pathogenic immune clones or DAMPs), (2) reactivation of endogenous repair mechanisms (e.g., caloric restriction(definition), metformin, GLP-1 agonists, transient OSK expression), and (3) cell, tissue, and organ replacement (e.g., stem cell–derived islets, FOXO3-enhanced MSCs). I highlight evolutionary insights from long-lived species, the centrality of chronic inflammation and fibrosis in age-related disease, and the transformative role of AI: from multi-omic aging clocks to agentic systems for target discovery and personalized longevity medicine. The tools to initiate this paradigm shift are already emerging; what is needed now is scientific rigor, interdisciplinary integration, and a collective commitment to treating aging as the fundamental driver of human morbidity and mortality.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.20944/preprints202511.1362.v1
- Canonical
- link ↗
- Fetched
- 2026-06-10 MST
Cite this
APA
Kovalev, M.A. (2025). What Is Aging, and How Can We Defeat It?. <em>Preprints.org</em>. https://doi.org/10.20944/preprints202511.1362.v1
Vancouver
Kovalev MA. What Is Aging, and How Can We Defeat It?. Preprints.org. 2025. doi:10.20944/preprints202511.1362.v1.
BibTeX
@unpublished{maxim2025WhatIs,
title = {What Is Aging, and How Can We Defeat It?},
author = {Maxim A. Kovalev},
journal = {Preprints.org},
year = {2025},
doi = {10.20944/preprints202511.1362.v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Translational Neurodegeneration 2025
Open access · CC-BY
Immunosenescence in aging and neurodegenerative diseases: evidence, key hallmarks, and therapeutic implications
Signal Transduction and Targeted Therapy 2022
Open access · CC-BY
Aging and aging-related diseases: from molecular mechanisms to interventions and treatments
Clinical Interventions in Aging 2025
Open access · CC-BY
The Ambiguous Role of HMGB1 Across the Hallmarks of Aging: A Narrative Review
Clinical Chemistry and Laboratory Medicine (CCLM) 2015
Open access · OA
The role of telomeres and vitamin D in cellular aging and age-related diseases
Life 2025
Open access · CC-BY
The Converging Roles of Nucleases and Helicases in Genome Maintenance and the Aging Process
Life (Basel, Switzerland) 2025
Open access · OA